269 related articles for article (PubMed ID: 3881913)
1. Use of calcium-channel blocking drugs in hypertrophic cardiomyopathy.
Rosing DR; Idänpään-Heikkilä U; Maron BJ; Bonow RO; Epstein SE
Am J Cardiol; 1985 Jan; 55(3):185B-195B. PubMed ID: 3881913
[TBL] [Abstract][Full Text] [Related]
2. Use of calcium channel blockers in hypertrophic cardiomyopathy.
Lorell BH
Am J Med; 1985 Feb; 78(2B):43-54. PubMed ID: 4038850
[TBL] [Abstract][Full Text] [Related]
3. Effects of calcium-channel blocking agents on left ventricular diastolic function in hypertrophic cardiomyopathy and in coronary artery disease.
Bonow RO
Am J Cardiol; 1985 Jan; 55(3):172B-178B. PubMed ID: 3881911
[TBL] [Abstract][Full Text] [Related]
4. Treatment of hypertrophic cardiomyopathy: relation to pathological mechanisms.
Kaltenbach M; Hopf R
J Mol Cell Cardiol; 1985 Jul; 17 Suppl 2():59-68. PubMed ID: 4040978
[TBL] [Abstract][Full Text] [Related]
5. Effects of diltiazem on left ventricular systolic and diastolic function in hypertrophic cardiomyopathy.
Betocchi S; Piscione F; Losi M A; Pace L; Boccalatte M; Perrone-Filardi P; Cappelli-Bigazzi ; Briguori C; Manganelli F; Ciampi Q; Salvatore M; Chiariello M
Am J Cardiol; 1996 Aug; 78(4):451-7. PubMed ID: 8752192
[TBL] [Abstract][Full Text] [Related]
6. [Beta-adrenergic blockers and calcium antagonists in hypertrophic cardiomyopathy].
Korovina EP
Klin Med (Mosk); 1998; 76(12):30-5. PubMed ID: 10067289
[TBL] [Abstract][Full Text] [Related]
7. Adverse hemodynamic and clinical effects of calcium channel blockade in pulmonary hypertension secondary to obliterative pulmonary vascular disease.
Packer M; Medina N; Yushak M
J Am Coll Cardiol; 1984 Nov; 4(5):890-901. PubMed ID: 6491082
[TBL] [Abstract][Full Text] [Related]
8. Persisting effect of Ca(2+)-channel blockers on left ventricular function in hypertrophic cardiomyopathy after 14 years' treatment.
Hartmann A; Schnell J; Hopf R; Kneissl G
Angiology; 1996 Aug; 47(8):765-73. PubMed ID: 8712479
[TBL] [Abstract][Full Text] [Related]
9. Verapamil therapy: a new approach to pharmacologic treatment of hypertrophic cardiomyopathy.
Rosing DR; Kent KM; Maron BJ; Condit J; Epstein SE
Chest; 1980 Jul; 78(1 Suppl):239-47. PubMed ID: 6995039
[TBL] [Abstract][Full Text] [Related]
10. [Hypertrophic obstructive cardiomyopathy: spontaneous course in comparison to long-term therapy with propranolol and verapamil].
Haberer T; Hess OM; Jenni R; Krayenbühl HP
Z Kardiol; 1983 Sep; 72(9):487-93. PubMed ID: 6415946
[TBL] [Abstract][Full Text] [Related]
11. Verapamil therapy: a new approach to the pharmacologic treatment of hypertrophic cardiomyopathy. I. Hemodynamic effects.
Rosing DR; Kent KM; Borer JS; Seides SF; Maron BJ; Epstein SE
Circulation; 1979 Dec; 60(6):1201-7. PubMed ID: 574066
[TBL] [Abstract][Full Text] [Related]
12. Combination therapy with calcium-channel blockers and beta blockers for chronic stable angina pectoris.
Leon MB; Rosing DR; Bonow RO; Epstein SE
Am J Cardiol; 1985 Jan; 55(3):69B-80B. PubMed ID: 2857518
[TBL] [Abstract][Full Text] [Related]
13. Clinical and hemodynamic evaluation of propranolol in combination with verapamil, nifedipine and diltiazem in exertional angina pectoris: a placebo-controlled, double-blind, randomized, crossover study.
Johnston DL; Lesoway R; Humen DP; Kostuk WJ
Am J Cardiol; 1985 Mar; 55(6):680-7. PubMed ID: 3883739
[TBL] [Abstract][Full Text] [Related]
14. Comparison of two calcium blockers on hemodynamics, left ventricular mass, and coronary vasodilatory in advanced hypertension.
Diamond JA; Krakoff LR; Goldman A; Coplan N; Gharavi A; Martin K; Goldsmith R; Henzlova MJ; Machac J; Phillips RA
Am J Hypertens; 2001 Mar; 14(3):231-40. PubMed ID: 11281234
[TBL] [Abstract][Full Text] [Related]
15. Verapamil-induced improvement in left ventricular diastolic filling and increased exercise tolerance in patients with hypertrophic cardiomyopathy: short- and long-term effects.
Bonow RO; Dilsizian V; Rosing DR; Maron BJ; Bacharach SL; Green MV
Circulation; 1985 Oct; 72(4):853-64. PubMed ID: 4040821
[TBL] [Abstract][Full Text] [Related]
16. Verapamil normalizes the response of left ventricular early diastolic filling to cold pressor test in asymptomatic and mildly symptomatic patients with hypertrophic cardiomyopathy.
Dimitrow PP; Surdacki A; Dubiel JS
Cardiovasc Drugs Ther; 1997 Dec; 11(6):741-6. PubMed ID: 9512868
[TBL] [Abstract][Full Text] [Related]
17. Oral verapamil effects on global and regional left ventricular diastolic filling in hypertrophic cardiomyopathy.
Yamagishi T; Ozaki M; Kusukawa R
Jpn Circ J; 1990 Nov; 54(11):1365-73. PubMed ID: 2287041
[TBL] [Abstract][Full Text] [Related]
18. Hemodynamic effects of verapamil in children and adolescents with hypertrophic cardiomyopathy.
Spicer RL; Rocchini AP; Crowley DC; Vasiliades J; Rosenthal A
Circulation; 1983 Feb; 67(2):413-20. PubMed ID: 6681534
[TBL] [Abstract][Full Text] [Related]
19. Comparison of acute reduction in left ventricular outflow tract pressure gradient in obstructive hypertrophic cardiomyopathy by disopyramide versus pilsicainide versus cibenzoline.
Kajimoto K; Imai T; Minami Y; Kasanuki H
Am J Cardiol; 2010 Nov; 106(9):1307-12. PubMed ID: 21029829
[TBL] [Abstract][Full Text] [Related]
20. Diastolic function in hypertrophic cardiomyopathy: effects of propranolol and verapamil on diastolic stiffness.
Hess OM; Grimm J; Krayenbuehl HP
Eur Heart J; 1983 Nov; 4 Suppl F():47-56. PubMed ID: 6686544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
